Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 08/06/20111 min de leitura
Generic Drug User Fee; Notice of Public Meeting; Extension of Comment Period
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is extending the comment period for the notice of public meeting, that appeared in the Federal Register of August 9, 2010 (75 FR 47820). In the notice, FDA requested comments to gather stakeholder input on the development of a generic drug user fee program. The Agency is taking this action to allow interested persons additional time to submit comments.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →